MiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1

被引:54
作者
Chen, Xiao-nan [1 ]
Wang, Ke-feng [1 ]
Xu, Zhen-qun [1 ]
Li, Shi-jie [1 ]
Liu, Qiang [1 ]
Fu, Dong-hui [1 ]
Wang, Xia [1 ]
Wu, Bin [1 ]
机构
[1] China Med Univ, Shengjing Hosp, Dept Urol, Shenyang 11004, Liaoning, Peoples R China
来源
CANCER CELL INTERNATIONAL | 2014年 / 14卷
关键词
miR-133b; Bcl-w; Akt1; Bladder cancer; Proliferation; Apoptosis; MIRNA EXPRESSION; UROTHELIAL CARCINOMAS; COLORECTAL-CANCER; TUMOR SUPPRESSORS; LUNG-CANCER; MICRORNAS; DEATH; IDENTIFICATION; ACTIVATION; MUTATIONS;
D O I
10.1186/s12935-014-0070-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: MiR-133b is a muscle-specific microRNA; it has a role in the formation of cardiocytes and the expression of myocardium ion channels by regulating target genes. Many human malignant tumors demonstrate a low expression of miR-133b, as noted in colorectal, lung, esophagus and bladder cancers, but the role of miR-133b in bladder cancer is unknown. Methods: The expression of miR-133b in clinical bladder cancer specimens and adjacent normal tissues was confirmed by stem-loop RT-PCR. We also analyzed the relationship between miR-133b expression and clinicopathological factors of bladder cancer. Bcl-w and Akt1 protein expression in 41 bladder cancer specimens and adjacent normal tissues was detected by Western blot. After transfection of miR-133b mimics or inhibitor into a T24 human bladder cancer cell line, Bcl-w and Akt1 protein and mRNA expression were examined by Western blot and RT-PCR, respectively. The effect of miR-133b on T24 cell proliferation and apoptosis was measured by CCK-8 tests and flow cytometry, respectively. Results: The expression of miR-133b in bladder cancer tissues from 41 patients was significantly down-regulated (P < 0.01); low expression of miR-133b was strongly associated with high-grade bladder cancer (P < 0.01). Bcl-w and Akt1 proteins were significantly overexpressed in bladder cancer tissues versus adjacent normal tissues (P < 0.01 for both). The expression of Akt1 and Bcl-w proteins and Akt1 mRNA, in T24 cells was significantly down-regulated or up-regulated after transfection of miR-133b mimics or inhibitor, respectively; however, there was no significant difference in Bcl-w mRNA expression. Transfection of HEK-293 T cells with miR-133b significantly suppressed a luciferase-reporter containing the Bcl-w or Akt 1 3'-untranslated regions. MiR-133b mimics significantly inhibited T24 cell proliferation, as well as increased T24 cell apoptosis (P < 0.05 and P < 0.01, respectively) while the miR-133b inhibitor increased and decreased these, respectively (P < 0.05 for both). Conclusions: MiR-133b may play a very important role in the proliferation and apoptosis of T24 cells by regulating the expression of Bcl-w and Akt1.
引用
收藏
页数:11
相关论文
共 40 条
  • [1] The Bcl-2 apoptotic switch in cancer development and therapy
    Adams, J. M.
    Cory, S.
    [J]. ONCOGENE, 2007, 26 (09) : 1324 - 1337
  • [2] MicroRNA pathways in flies and worms: Growth, death, fat, stress, and timing
    Ambros, V
    [J]. CELL, 2003, 113 (06) : 673 - 676
  • [3] AKT1 mutations in bladder cancer: identification of a novel oncogenic mutation that can co-operate with E17K
    Askham, J. M.
    Platt, F.
    Chambers, P. A.
    Snowden, H.
    Taylor, C. F.
    Knowles, M. A.
    [J]. ONCOGENE, 2010, 29 (01) : 150 - 155
  • [4] Bcl-w promotes gastric cancer cell invasion by inducing matrix metalloproteinase-2 expression via phosphoinositide 3-kinase, Akt, and Sp1
    Bae, In Hwa
    Park, Myung-Jin
    Yoon, Sung Hwan
    Kang, Sung Wook
    Lee, Seung-Sook
    Choi, Kyung-Mi
    Um, Hong-Duck
    [J]. CANCER RESEARCH, 2006, 66 (10) : 4991 - 4995
  • [5] MicroRNA expression profiling of human metastatic cancers identifies cancer gene targets
    Baffa, Raffaele
    Fassan, Matteo
    Volinia, Stefano
    O'Hara, Brian
    Liu, Chang-Gong
    Palazzo, Juan P.
    Gardiman, Marina
    Rugge, Massimo
    Gomella, Leonard G.
    Croce, Carlo M.
    Rosenberg, Anne
    [J]. JOURNAL OF PATHOLOGY, 2009, 219 (02) : 214 - 221
  • [6] Identification by Real-time PCR of 13 mature microRNAs differentially expressed in colorectal cancer and non-tumoral tissues
    Bandres, E.
    Cubedo, E.
    Agirre, X.
    Malumbres, R.
    Zarate, R.
    Ramirez, N.
    Abajo, A.
    Navarro, A.
    Moreno, I.
    Monzo, M.
    Garcia-Foncillas, J.
    [J]. MOLECULAR CANCER, 2006, 5 (1)
  • [7] MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004)
    Bartel, David P.
    [J]. CELL, 2007, 131 (04) : 11 - 29
  • [8] A miRNA expression signature that separates between normal and malignant prostate tissues
    Carlsson, Jessica
    Davidsson, Sabina
    Helenius, Gisela
    Karlsson, Mats
    Lubovac, Zelmina
    Andren, Ove
    Olsson, Bjorn
    Klinga-Levan, Karin
    [J]. CANCER CELL INTERNATIONAL, 2011, 11
  • [9] Distinct MicroRNA Alterations Characterize High- and Low-Grade Bladder Cancer
    Catto, James W. F.
    Miah, Saiful
    Owen, Helen C.
    Bryant, Helen
    Myers, Katie
    Dudziec, Ewa
    Larre, Stephane
    Milo, Marta
    Rehman, Ishtiaq
    Rosario, Derek J.
    Di Martino, Erica
    Knowles, Margaret A.
    Meuth, Mark
    Harris, Adrian L.
    Hamdy, Freddie C.
    [J]. CANCER RESEARCH, 2009, 69 (21) : 8472 - 8481
  • [10] miR-145 and miR-133a function as tumour suppressors and directly regulate FSCN1 expression in bladder cancer
    Chiyomaru, T.
    Enokida, H.
    Tatarano, S.
    Kawahara, K.
    Uchida, Y.
    Nishiyama, K.
    Fujimura, L.
    Kikkawa, N.
    Seki, N.
    Nakagawa, M.
    [J]. BRITISH JOURNAL OF CANCER, 2010, 102 (05) : 883 - 891